Absorbable hemostatic agents are commonly used after endoscopic sinus surgery (ESS). MPH® (Microporous Polysaccharide Hemospheres) is a novel hemostatic powder that is rapidly absorbed. The goal of this study was to examine the eff ects of MPH on bleeding after ESS.STUDY DESIGN: Prospective blinded randomized controlled study.
METHODS:Patients undergoing bilateral ESS for CRS by the same surgeon were randomized to treatment with MPH of only one-side of the nose at the conclusion of surgery. The other side was untreated and served as a control. All patients received standard postoperative management. Patients completed symptom diaries using visual analogue scales (VAS, scored out of 100) at baseline and through postoperative day (POD) 30. Outcomes including bleeding, pain, obstruction, and nasal discharge were recorded separately for left and right sides.
RESULTS:Forty patients (19 men, 21 women) with an average age of 48.6 yrs were included. There were no complications and all patients were discharged home the same day. The mean bleeding score on POD 1 for MPH-treated sides was 22.5 versus 39.0 for untreated controls (mean reduction 16.5, p<0.0001, 95% CI -23.2 to -9.7). The scores for bleeding at baseline and at all other post-treatment days were not signifi cantly diff erent (p>0.05). There were no other signifi cant diff erences between MPH-treated and control sides in any of the other variables measured throughout the study period.CONCLUSION: Application of MPH signifi cantly reduces bleeding in the immediate postoperative period following ESS.